Prevalence of nasal staphylococcus aureus carriage in the patients undergoing hemodialysis and evaluation of risk factors and laboratory parameters

Renal Failure

Volumn 33, Issue 5, 2011, Pages 494-498

  Çelik, Gülperi ^a   Gülcan, Aynur ^b   Dikici, Nebahat ^a   Gülcan, Erim ^c  

^a SELCUK UNIVERSITY   (Turkey)

^b Kutahya Evliya Celebi State Hospital   (Turkey)

^c ATATURK UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; laboratory parameters; nasal carriage; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; PHENAZOPYRIDINE PLUS SULFAMETHOXAZOLE PLUS TRIMETHOPRIM; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATION; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; URBAN AREA;

ADULT; AGED; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TURKEY;

EID: 79956267166     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.573896     Document Type: Article

References (41)

1. Melles DC, Taylor KL, Fattom AI, et al. Serotyping of Dutch Staphylococcus aureus strains from carriage and infection. FEMS Immunol Med Microbiol. 2008;52(2):287-292. (Pubitemid 351248435)
2. Kluytmans JA, Belkum AV, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-520. (Pubitemid 27359263)
3. Kypraios T, O' Neill PD, Huang SS, et al. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infect Dis. 2010;16(10):29.
4. Tamer A, Karabay O, Ekerbicer H. Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients. Jpn J Infect Dis. 2006;59(1):10-14.
5. Ucuncu H, Uslu H, Ozbek A, et al. Comparison of the bacterial flora of the nasal vestibule and cavity in hemodialysis patients. Acta Otorhinolaryngol Ital. 2009;29(5):251-254.
6. Koziol-Montewka M, Szczepanik A, Baranowicz I, et al. The investigation of Staphylococcus aureus and coagulasenegative staphylococci nasal carriage among patients undergoing hemodialysis. Microbiol Res. 2006;161(4):281-287. (Pubitemid 44634262)
7. Peña C, Fernández-Sabe N, Domínguez MA, et al. Staphylococcus aureus nasal carriage in patients on hemodialysis: Role of cutaneous colonization. J Hosp Infect. 2004;58(1):20-27. (Pubitemid 39207107)
8. Lu PL, Tsai JC, Chiu YW, et al. Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members. Nephrol Dial Transplant. 2008;23(5):1659-1665.
9. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of methicillin resistant Staphylococcus aureus: The prevalence, patients at risk and the effect of elimination on outcomes among outclinic hemodialysis patients. Eur J Med Res. 2007;12(7):284-288. (Pubitemid 47207728)
10. Nouwen J, Schouten J, Schneebergen P, et al. Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J Clin Microbiol. 2006;44(6):2233-2236. (Pubitemid 43902181)
11. Ritzau J, Hoffman RM, Tzamaloukas AH. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheterrelated staphylococcal infections. Literature synthesis. Perit Dial Int. 2001;21(5):471-479. (Pubitemid 32998453)
12. Crabtree JH, Hadnott LL, Burchette RJ, et al. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial. 2000;16:271-275.
13. Berman DS, Schaefler S, Simberkoff MS. S. aureus colonization in intravenous drug abusers, dialysis patients and diabetes. J Infect Dis. 1987;155(4):829-831.
14. Coronado F, Nicholas JA, Wallace BJ, et al. Communityassociated methicillin-resistant Staphylococcus aureus skin infections in a religious community. Epidemiol Infect. 2007;135(3): 492-501. (Pubitemid 46443435)
15. Weinke T, Schiller R, Fehrenbach FJ, et al. Association between S. aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992;11(11):985-989. (Pubitemid 23045370)
16. Nouwen JL, Fieren MW, Snijders S, et al. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int. 2005;67(3): 1084-1092. (Pubitemid 41623334)
17. Francioli P, Masur H. Complications of Staphylococcus aureus bacteremia: Occurrence in patients undergoing long-term hemodialysis. Arch Intern Med. 1982;142(9):1655-1658. (Pubitemid 12011191)
18. Johnson DW, MacGinley R, Kay TD, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed hemodialysis catheters. Nephrol Dial Transplant. 2002;17(10):1802-1807. (Pubitemid 35174293)
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard. CLSI Document M02-A9. 9th ed. Wayne, PA: CLSI; 2006.
20. Del Rio A, Cervera C, Moreno A, et al. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2009;48(Suppl. 4):S246-S253.
21. Piraino B. Staphylococcus aureus infections in dialysis patients: Focus on prevention. ASAIO J. 2000;46(6):S13-S17.
22. Saxena AK, Panhotra BR. The prevalence of nasal carriage of Staphylococcus aureus and associated vascular access-related septicemia among patients on hemodialysis in Al-Hasa region of Saudi Arabia. Saudi J Kidney Dis Transplant. 2003;14(1):30-38. (Pubitemid 36289794)
23. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751-762. (Pubitemid 41688980)
24. Sehgal AR, Silver MR, Covinsky KE, et al. Use of standardized ratios to examine variability in hemodialysis vascular access across facilities. Am J Kidney Dis. 2000;35:275-281. (Pubitemid 30070850)
25. Von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344: 11-16. (Pubitemid 32064839)
26. Jean G, Charra B, Chazot C, et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron. 2002;91(3):399-405. (Pubitemid 34765237)
27. Bogut A, Koziol-Montewka M, Baranowicz I, et al. Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing hemodialysis treatment. New Microbiol. 2007;30(2):149-154. (Pubitemid 46984121)
28. Altoparlak U, Kadanali A, Celebi S. Slime factor positivity in coagulase negative staphylococci isolated from nasal samples of hemodialysis patients. Int J Clin Pract. 2004;58(12): 1112-1114. (Pubitemid 40123744)
29. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial. 2003;16(1):30-37. (Pubitemid 37356764)
30. Resić H, Corić A, Dedeić-Ljubović A, et al. Prevalence of MRSA infections in patients on hemodialysis. Med Pregl. 2007;60(2):97-100.
31. Lu PL, Chin LC, Peng CF, et al. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol. 2005;43(1):132-139.
32. Duran N, Ocak S, Eskiocak AF. Staphylococcus aureus nasal carriage among the diabetic and non-diabetic hemodialysis patients. Int J Clin Pract. 2006;60(10):1204-1209. (Pubitemid 44363656)
33. Saxena AK, Panhotra BR, Venkateshappa CK, et al. The impact of nasal carriage of methicillin-resistant and methicillinsusceptible Staphylococcus aureus (MRSA & MSSA) on vascular access-related septicemia among patients with type-II diabetes on dialysis. Ren Fail. 2002;24(6):763-777. (Pubitemid 35404069)
34. Saxena AK, Panhotra BR, Uzzaman W, et al. The role of the Staphylococcus aureus nasal carriage and type of vascular access in the outcome of high-risk patients on hemodialysis. J Vasc Access. 2002;3(2):74-79. (Pubitemid 34785311)
35. Leman R, Alvarado-Ramy F, Pocock S, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population. Infect Control Hosp Epidemiol. 2004;25(2): 121-125. (Pubitemid 38252340)
36. Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 2004;25(6):481-484. (Pubitemid 38758493)
37. Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: Strengths, weaknesses and future prospects. J Antimicrob Chemother. 2009;64(1):9-15.
38. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33(1):3-8. (Pubitemid 40585492)
39. Boelaert JR, Van Landuyt HW, De Baere YA, et al. Staphylococcus aureus infections in hemodialysis patients: Pathophysiology and use of nasal mupirocin for prevention. J Chemother. 1995;7(3):49-53.
40. Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. Am J Infect Control. 2007;35(2): 106-114. (Pubitemid 46283602)
41. Koziol-Montewka M, Szczepanik A, Baranowicz I, et al. The investigation of Staphylococcus aureus and coagulasenegative staphylococci nasal carriage among patients undergoing hemodialysis. Microbiol Res. 2006;161(4):281-287. (Pubitemid 44634262)